|
No images? Click here 
Drew Armstrong Executive Editor, Endpoints News dupa, We just dropped two timely episodes of Post-Hoc Live you won’t want to miss. In our newest episode, I talk with Endpoints senior correspondent Andrew Dunn and machine-learning engineer Abhi Mahajan about how AI is reshaping drug development. We dig into the technology’s growing complexity, biopharma’s uneven response, and what’s coming next for discovery, regulation and funding. And earlier this week, I sat down with former CDC Director Mandy Cohen and Endpoints reporter Max Bayer to talk about RFK Jr.’s dramatic move to fire the CDC’s vaccine advisory panel, ACIP — and what it means for public health, vaccine policy and pandemic preparedness. Whether you’re tuning in on your commute or catching up between meetings, both episodes are packed with insights you’ll want to hear. 🎧 Listen or watch now: Hope you’ll tune in, Drew Armstrong P.S. Want expert analysis from the newsroom — plus on-the-ground dispatches from medical meetings and conferences? Check the box next to Post-Hoc in your reader profile to start receiving the newsletter. 
2029 Becker Drive; Lawrence, Kansas 66047 USA Privacy and: help@endpointsnews.com    Worldwide made. Thanks for reading. |
